About Index Trending news
Analyze
Top 50 Pricing
Northwest Biotherapeutics

Northwest Biotherapeutics

Work at Northwest Biotherapeutics? Add yourself to this profile

Northwest Biotherapeutics

NW Bio is a biotech company developing immune therapies (DCVax®) to treat a broad range of cancers including brain, prostate & ovarian.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Post-IPO debt
$10,000,000
Post-IPO equity
$40,000,000
Employees

Unknown size

Locations
HQ
Headquarters
The Motley Fool

Why Northwest Biotherapeutics, Accuray, and U.S. Steel Slumped Today --

Stock markets